English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
YOU ARE INVITED to discuss future directions of CML at the iCMLf Forum at ASH on Dec 9
November 2022 - We are looking forward to seeing you at the upcoming ASH Annual Meeting and welcoming you to our iCMLf Forum: ‘New next big challenges in CML?’
At this forum, we will take a look at future directions of CML. What are the next big challenges in CML? What are the most promising new approaches? What research questions need to be answered to help us to move closer to a cure for CML?
Our speakers and panellists of renowned experts in the field will share their perspectives and discuss key challenges in CML in the coming years. You are invited to join the discussion!
Numbers are limited. Please register ASAP by emailing arlene@cml-foundation.org
Read the iCMLf’s 2021-2022 Annual Report
We’re pleased to share the 2021-2022 iCMLf Annual Report. To begin, it’s a pleasure to start with a note from the Chairman and Chief Executive.
Dear Friends and Colleagues,
This year as we slowly work our way into a new normal after the peak of the pandemic, our efforts have solidified into two key areas:
- Harnessing our power through global research
- Raising the bar for CML best practice around the world
As we began our financial year in September 2021 the Omicron variant of SARS-CoV-2 had yet to arrive and we were still collecting cases for the iCMLf COVID-19 registry. Two hundred physicians from 58 countries submitted a total of 1,050 cases giving a truly global perspective of the impact of COVID-19 on people with CML. The four publications from this registry data have all shown that people with well-controlled CML have the same risk profile as that of the general population for outcomes of COVID-19. We are incredibly proud of the work and global collaboration that resulted from this registry in spite of the devastation that made it necessary.
iCMLf Forum at ASH discusses future directions of CML - Save the date!
October 2022 - Are you coming to the ASH Annual Meeting this year? And would you like to join us for a multi-stakeholder discussion on future directions of CML?
If so, please save the date for this year’s iCMLf Forum hat will take place on Friday 9th December from 12-3 pm.
Download the ‘Save-the-date’ invitation here
The 2022 John Goldman charity Fun Run raised over $1,700 so far - You can still join the run virtually!
October 2022 - The 2022 John Goldman charity Fun Run raised over $1,700 so far. What a great achievement!
A special thank you to all for participating in our charity run T-shirt and to everyone for your generous contributions to support the work of the iCMLf. These funds will make a huge difference to help the iCMLf to support young scientists and physicians in low- and middle-income countries.
The good news: You can still do your own 5 km run and join the community virtually.
Meet Dr Vasile Musteata, 2022 iCMLf Prize Nominee
It’s a pleasure to share our second featured nominee for the iCMLf Prize in 2022, Dr Vasile Musteata, State Medical and Pharmaceutical University, Moldova.
Dr Musteata is an associate professor and hemato-oncologist, EACR ambassador, iCMLf representative for Moldova and also participates in research for the European LeukemiaNet Institution. Dr Musteata’s research and knowledge has been published in more than 150 articles and abstracts, and 10-years ago in 2012, he successfully completed the ERSAP Preceptorship Program in hematologic malignancies at MD Anderson Cancer Center, Texas, USA.
An update on the iCMLf’s Genomics and TFR Alliances
We are pleased to share an update on the iCMLf’s Genomics and TFR Alliances. 2022 has been a great year of progress for them both:
